Aquestive Therapeutics (NASDAQ:AQST) executives used the company’s fourth-quarter 2025 earnings call to outline a path ...
Study to test effectiveness of Instructional System Designs (ISD) model for Intranasal SPC-15 ENGLEWOOD CLIFFS, NJ, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Silo Pharma (SILO), Inc. (“the Company”), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results